The ubiquitin-specific protease USP28 is required for MYC stability (original) (raw)

• Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84, 81–154 (2002).
  Article CAS Google Scholar
• Salghetti, S. E., Kim, S. Y. & Tansey, W. P. Destruction of MYC by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize MYC. EMBO J. 18, 717–726 (1999).
  Article CAS Google Scholar
• Bahram, F., von der Lehr, N., Cetinkaya, C. & Larsson, L. G. c-MYC hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95, 2104–2110 (2000).
  CAS PubMed Google Scholar
• Welcker, M. et al. The FBW7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-MYC protein degradation. Proc. Natl Acad. Sci. USA 101, 9085–9090 (2004).
  Article CAS Google Scholar
• Yada, M. et al. Phosphorylation-dependent degradation of c-MYC is mediated by the F-box protein FBW7. EMBO J. 23, 2116–2125 (2004).
  Article CAS Google Scholar
• Yeh, E. et al. A signalling pathway controlling c-MYC degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308–318 (2004).
  Article CAS Google Scholar
• Gregory, M. A. & Hann, S. R. c-MYC proteolysis by the ubiquitin-proteasome pathway: stabilization of c-MYC in Burkitt's lymphoma cells. Mol. Cell Biol. 20, 2423–2435 (2000).
  Article CAS Google Scholar
• Malempati, S. et al. Aberrant stabilization of c-MYC protein in some lymphoblastic leukemias. Leukemia 20, 1572–1581 (2006).
  Article CAS Google Scholar
• Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E. & Tansey, W. P. Skp2 regulates myc protein stability and activity. Mol. Cell 11, 1177–1188 (2003).
  Article CAS Google Scholar
• von der Lehr, N. et al. The F-box protein Skp2 participates in c-MYC proteosomal degradation and acts as a cofactor for c-MYC-regulated transcription. Mol. Cell 11, 1189–1200 (2003).
  Article CAS Google Scholar
• Gross-Mesilaty, S. et al. Basal and human papillomavirus E6 oncoprotein-induced degradation of MYC proteins by the ubiquitin pathway. Proc. Natl Acad. Sci. USA 95, 8058–8063 (1998).
  Article CAS Google Scholar
• Nijman, S. M. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773–786 (2005).
  Article CAS Google Scholar
• Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992).
  Article CAS Google Scholar
• Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G. & Evan, G. I. A modified oestrogen receptor ligand binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686–1690 (1995).
  Article CAS Google Scholar
• Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431–437 (2004).
  Article CAS Google Scholar
• Brummelkamp, T. R. et al. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nature Chem. Biol. 2, 202–206 (2006).
  Article CAS Google Scholar
• Amati, B., Littlewood, T. D., Evan, G. I. & Land, H. The c-MYC protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 13, 5083–5087 (1993).
  Article Google Scholar
• Leone, G. et al. MYC requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105–113 (2001).
  Article CAS Google Scholar
• Dansen, T. B., Whitfield, J., Rostker, F., Brown-Swigart, L. & Evan, G. I. Specific requirement for Bax, not Bak, in MYC-induced apoptosis and tumor suppression in vivo. J. Biol. Chem. 281, 10890–10895 (2006).
  Article CAS Google Scholar
• Rothermund, K. et al. c-MYC-independent restoration of multiple phenotypes by two c-MYC target genes with overlapping functions. Cancer Res. 65, 2097–2107 (2005).
  Article CAS Google Scholar
• Benitah, S. A., Frye, M., Glogauer, M. & Watt, F. M. Stem cell depletion through epidermal deletion of Rac1. Science 309, 933–935 (2005).
  Article Google Scholar
• Park, Y. B. et al. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 133, 105–111 (2002).
  Article CAS Google Scholar
• Zhang, D., Zaugg, K., Mak, T. W. & Elledge, S. J. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126, 529–542 (2006).
  Article CAS Google Scholar
• Koepp, D. M. et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFBW7 ubiquitin ligase. Science 294, 173–177 (2001).
  Article CAS Google Scholar
• Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316–322 (2001).
  Article CAS Google Scholar
• Bhattacharya, S. et al. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22, 2443–2451 (2003).
  Article CAS Google Scholar
• Sutterlüty, H. et al. e45skp2 promotes p27kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol. 1, 207–214 (1999).
  Article Google Scholar
• Sorensen, C. S. et al. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex–Cdh1 and cyclin A–Cdk2 during cell cycle progression. Mol. Cell Biol. 21, 3692–3703 (2001).
  Article CAS Google Scholar
• Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. & Pagano, M. Control of the SCF(Skp2–Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428, 190–193 (2004).
  Article CAS Google Scholar
• Welcker, M. et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12, 381–392 (2003).
  Article CAS Google Scholar
• Welcker, M., Orian, A., Grim, J. A., Eisenman, R. N. & Clurman, B. E. A Nucleolar isoform of the FBW7 ubiquitin ligase regulates c-MYC and cell size. Curr. Biol. 14, 1852–1857 (2004).
  Article CAS Google Scholar
• Kee, Y., Lyon, N. & Huibregtse, J. M. The Rsp5 ubiquitin ligase is coupled to and antagonized by the Ubp2 deubiquitinating enzyme. EMBO J. 24, 2414–2424 (2005).
  Article CAS Google Scholar
• Li, M., Brooks, C. L., Kon, N. & Gu, W. A dynamic role of HAUSP in the p53–Mdm2 pathway. Mol. Cell 13, 879–886 (2004).
  Article CAS Google Scholar
• van Drogen, F. et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 23, 37–48 (2006).
  Article CAS Google Scholar
• Gomez-Roman, N., Grandori, C., Eisenman, R. N. & White, R. J. Direct activation of RNA polymerase III transcription by c-MYC. Nature 421, 290–294 (2003).
  Article CAS Google Scholar
• Grandori, C. et al. c-MYC binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biol. 7, 311–318 (2005).
  Article CAS Google Scholar
• Sansom, O. J. et al. MYC deletion rescues Apc deficiency in the small intestine. Nature 446, 676–679 (2007).
  Article CAS Google Scholar
• van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250 (2002).
  Article CAS Google Scholar
• Oskarsson, T. & Trumpp, A. The MYC trilogy: lord of RNA polymerases. Nature Cell Biol. 7, 215–217 (2005).
  Article CAS Google Scholar
• Arabi, A., Rustum, C., Hallberg, E. & Wright, A. P. Accumulation of c-MYC and proteasomes at the nucleoli of cells containing elevated c-MYC protein levels. J. Cell Sci. 116, 1707–1717 (2003).
  Article CAS Google Scholar
• Li, Z., Wang, D., Messing, E. M. & Wu, G. VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. EMBO Rep. 6, 373–378 (2005).
  Article CAS Google Scholar
• Herbst, A. et al. A conserved element in MYC that negatively regulates its proapoptotic activity. EMBO Rep. 6, 177–183 (2005).
  Article CAS Google Scholar
• Hemann, M. T. et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436, 807–811 (2005).
  Article CAS Google Scholar
• Benassi, B. et al. c-MYC phosphorylation is required for cellular response to oxidative stress. Mol. Cell 21, 509–519 (2006).
  Article CAS Google Scholar
• Ngo, V. N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106–110 (2006).
  Article CAS Google Scholar
• Shachaf, C. M. et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112–1117 (2004).
  Article CAS Google Scholar
• Leung-Toung, R. et al. Thiol proteases: inhibitors and potential therapeutic targets. Curr. Med. Chem. 13, 547–581 (2006).
  Article CAS Google Scholar
• Brummelkamp, T. R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243–247 (2002).
  Article CAS Google Scholar
• Adhikary, S. et al. The ubiquitin ligase HectH9 regulates transcriptional activation by MYC and is essential for tumor cell proliferation. Cell 123, 409–421 (2005).
  Article CAS Google Scholar